Author:
Kim Haeryoung,Leow Wei-Qiang,Lo Regina,Mendoza Paulo Giovanni L.,Chan Anthony Wing-Hung
Publisher
Springer Nature Singapore
Reference22 articles.
1. Torbenson MS. Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes. Hum Pathol. 2021;112:86–101.
2. Torbenson MS, Ng IOL, Park YN, Roncalli M, Sakamoto M. Hepatocellular carcinoma. In: WHO Classification of Tumours Editorial Board, editor. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2019. p. 229–39.
3. Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Sanada J, Koda W, Minami T, Inoue D, Yoshida K, Yamashita T, Yamashita T, Kaneko S, Takamura H, Ohta T, Ikeda H, Nakanuma Y, Kita R, Gabata T. Hepatocellular carcinoma with beta-catenin mutation: imaging and pathologic characteristics. Radiology. 2015;275:708–17.
4. Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol. 1999;155:703–10.
5. Aigelsreiter A, Neumann J, Pichler M, Halasz J, Zatloukal K, Berghold A, Douschan P, Rainer F, Stauber R, Haybaeck J, Denk H, Lackner C. Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis. Liver Int. 2017;37:600–10.